September 2025: Another Study Says Ozempic Increases Risk of Vision Loss A study published in the Journal of the American Medical Association (JAMA) has concluded that taking semaglutide drugs like Ozempic raises the risk of a certain type of blindness by 1.76 times
We use FDA-approved GLP-1 medications, along with ongoing monitoring and lifestyle support, to ensure safe and effective weight loss
To withdraw your question, please press star one one again
Food and Drug Administration (2023) Tirzepatide versus semaglutide once weekly in patients with Type 2 diabetes, The New England Journal of Medicine (2021) Johns Hopkins scientists say risk of pancreatitis doubles for those taking new class of diabetes drugs, John Hopkins Medicine (2013) Normal and disordered gastric emptying in diabetes: Recent insights into (patho)physiology, management and impact on glycaemic control, Diabetologia (2022) GLP-1 receptor agonists and the risk of thyroid cancer, American Diabetes Association (2022) Mounjaro highlights of prescribing information, The U.S
From 2019 to 2024, the percentage of patients prescribed one of these three GLP-1 drugs increased from .03 to .68 percenta staggering 2,029% increase